Cargando…

Skin Mycobiome of Psoriasis Patients is Retained during Treatment with TNF and IL-17 Inhibitors

Background: Biological treatment relieves refractory skin lesions in patients with psoriasis; however, changes in the fungal microbiome (the mycobiome) on the skin are unclear. Methods: The skin mycobiome of psoriasis patients treated with TNF inhibitors (TNFi, n = 5) and IL-17 inhibitors (IL-17i, n...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koike, Yuta, Kuwatsuka, Sayaka, Nishimoto, Katsutaro, Motooka, Daisuke, Murota, Hiroyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312082/ https://www.ncbi.nlm.nih.gov/pubmed/32486022 http://dx.doi.org/10.3390/ijms21113892

Ejemplares similares

An interleukin-17 inhibitor successfully treated a complicated psoriasis and psoriatic arthritis patient with hepatitis B virus infection and end-stage kidney disease on hemodialysis
por: Koike, Yuta, et al.
Publicado: (2019)

Skin Inflammation Modulation via TNF-α, IL-17, and IL-12 Family Inhibitors Therapy and Cancer Control in Patients with Psoriasis
por: Costache, Daniel Octavian, et al.
Publicado: (2022)

IL-17A and TNF-α inhibitors induce multiple molecular changes in psoriasis
por: Dong, Qiang, et al.
Publicado: (2022)

Drug survival of ixekizumab, TNF inhibitors, and other IL‐17 inhibitors in real‐world patients with psoriasis: The Corrona Psoriasis Registry
por: Lockshin, Benjamin, et al.
Publicado: (2021)

Paradoxical Reactions to Anti-TNFα and Anti-IL-17 Treatment in Psoriasis Patients: Are Skin and/or Gut Microbiota Involved?
por: Jiraskova Zakostelska, Zuzana, et al.
Publicado: (2023)

Dynamics of Skin Mycobiome in Infants
por: Zhu, Ting, et al.
Publicado: (2020)

A case of bilateral plantar pseudo-Kaposi sarcoma successfully treated with propranolol
por: Mine, Takaaki, et al.
Publicado: (2021)

Structures of the Skin Microbiome and Mycobiome Depending on Skin Sensitivity
por: Keum, Hye Lim, et al.
Publicado: (2020)

IL-17 and TNF synergistically modulate cytokine expression while suppressing melanogenesis: potential relevance to psoriasis
por: Wang, Claire Q.F., et al.
Publicado: (2013)

The IL-17 Family of Cytokines in Psoriasis: IL-17A and Beyond
por: Brembilla, Nicolo Costantino, et al.
Publicado: (2018)

Serum Levels of TNF-α, IL-12/23p40, and IL-17 in Plaque Psoriasis and Their Correlation with Disease Severity
por: Kyriakou, Aikaterini, et al.
Publicado: (2014)

The Role of IL-17 Cytokines in Psoriasis
por: Mosca, Megan, et al.
Publicado: (2021)

Tinea Capitis Caused by Microsporum audouninii: A Report of Two Cases from Côte D’Ivoire, West Africa
por: Yotsu, Rie Roselyne, et al.
Publicado: (2021)

Serum Levels of TNF-α, IFN-γ, IL-6, IL-8, IL-12, IL-17, and IL-18 in Patients With Active Psoriasis and Correlation With Disease Severity
por: Arican, Ozer, et al.
Publicado: (2005)

Neutral Processes Drive Seasonal Assembly of the Skin Mycobiome
por: Tong, Xinzhao, et al.
Publicado: (2019)

The contribution of IL-17 to the development of autoimmunity in psoriasis
por: Furue, Masutaka, et al.
Publicado: (2019)

Compositional Alteration of Gut Microbiota in Psoriasis Treated with IL-23 and IL-17 Inhibitors
por: Huang, Yu-Huei, et al.
Publicado: (2023)

Defect of IL17 Signaling, but Not Centrinone, Inhibits the Development of Psoriasis and Skin Papilloma in Mouse Models
por: Jin, Ben, et al.
Publicado: (2022)

Role of the IL-23/IL-17 Axis in Psoriasis and Psoriatic Arthritis: The Clinical Importance of Its Divergence in Skin and Joints
por: Boutet, Marie-Astrid, et al.
Publicado: (2018)

A case of Merkel cell carcinoma development under treatment with a Janus kinase inhibitor
por: Koike, Yuta, et al.
Publicado: (2017)

Aged related human skin microbiome and mycobiome in Korean women
por: Kim, Hye-Jin, et al.
Publicado: (2022)

Infant Mode of Delivery Shapes the Skin Mycobiome of Prepubescent Children
por: Wang, Yan-Ren, et al.
Publicado: (2022)

Overrepresentation of IL-17A and IL-22 Producing CD8 T Cells in Lesional Skin Suggests Their Involvement in the Pathogenesis of Psoriasis
por: Res, Pieter C. M., et al.
Publicado: (2010)

Notch-Hes1 Signaling Regulates IL-17A(+)γδ(+)T Cell Expression and IL-17A Secretion of Mouse Psoriasis-Like Skin Inflammation
por: Wang, Yanqin, et al.
Publicado: (2020)

Serum Levels of TNF-α, IL-12/23 p40, and IL-17 in Psoriatic Patients with and without Nail Psoriasis: A Cross-Sectional Study
por: Kyriakou, Aikaterini, et al.
Publicado: (2014)

Fibroblast growth factor 2 accelerates the epithelial–mesenchymal transition in keratinocytes during wound healing process
por: Koike, Yuta, et al.
Publicado: (2020)

BATF2 prevents T-cell-mediated intestinal inflammation through regulation of the IL-23/IL-17 pathway
por: Kayama, Hisako, et al.
Publicado: (2019)

The Clinical Significance of Simultaneous IL-17A and IL-17F Blockade in Psoriasis Non-Responding to Anti-IL17A Therapy
por: Kokolakis, Georgios, et al.
Publicado: (2022)

The effects of IL-17/IL-17R inhibitors on atherosclerosis in psoriasis and psoriatic arthritis: A protocol for systematic review and meta analysis
por: Liu, Ningyuan, et al.
Publicado: (2021)

An IL17RA frameshift variant in a Holstein cattle family with psoriasis-like skin alterations and immunodeficiency
por: Häfliger, Irene M., et al.
Publicado: (2020)

Dual targeting of mTOR/IL-17A and autophagy by fisetin alleviates psoriasis-like skin inflammation
por: Roy, Tithi, et al.
Publicado: (2023)

Relevance of Inflammatory Cytokine mRNA Expression of Tumour Necrosis Factor- Alpha (TNF α), Interleukin 17A (IL 17A) and Interleukin 6 (IL 6) in Indian Patients with Psoriasis
por: Shah, Saiqa R., et al.
Publicado: (2022)

TNF, IL12B, and IFNG Gene Polymorphisms in Serbian Patients with Psoriasis
por: Popadic, Svetlana, et al.
Publicado: (2015)

Differentiation of IL-26(+) T(H)17 intermediates into IL-17A producers via epithelial crosstalk in psoriasis
por: Fries, Anissa, et al.
Publicado: (2023)

The Immunologic Role of IL-17 in Psoriasis and Psoriatic Arthritis Pathogenesis
por: Blauvelt, Andrew, et al.
Publicado: (2018)

Role of IL-17 in plaque psoriasis: therapeutic potential of ixekizumab
por: Hanley, Tessa L, et al.
Publicado: (2017)

IL-17A in Psoriasis and Beyond: Cardiovascular and Metabolic Implications
por: von Stebut, Esther, et al.
Publicado: (2020)

Secukinumab: The Anti-IL-17A Biologic for the Treatment of Psoriasis
por: Fargnoli, Maria Concetta
Publicado: (2019)

Osmoregulation and the human mycobiome
por: Saxena, Abhishek, et al.
Publicado: (2014)

Crohn’s disease exacerbated by IL-17 inhibitors in patients with psoriasis: a case report
por: Ju, Jingyi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tem1asoi1k9tgu556ehnenbu71